Topical retinoids are vitamin A derivatives applied to the skin that work by binding to receptors inside cells and changing how those cells grow, divide, and shed. They are among the most studied ingredients in dermatology, backed by decades of clinical use for acne, sun damage, and fine lines. But the term “retinoid” covers a wide range of molecules with very different potencies, and the gap between what a prescription tretinoin cream does and what an over-the-counter retinol serum does is larger than most people realize.
How Retinoids Work in the Skin
All topical retinoids share a common endpoint: they influence gene activity inside skin cells. When a retinoid molecule reaches the cell nucleus, it binds to retinoic acid receptors, which then switch certain genes on or off. This changes how fast cells turn over, how much collagen the skin produces, and how pigment is distributed. The downstream effects include thinner, less sticky layers of dead skin cells (which is why pores unclog), increased collagen production deeper in the skin, and a more even distribution of melanin.
The key molecule doing the heavy lifting is retinoic acid, also called tretinoin. It binds directly to those nuclear receptors without needing any conversion. Every other form of retinoid you encounter, whether retinol, retinaldehyde, or retinyl palmitate, must be converted into retinoic acid by your skin’s own enzymes before it can do anything meaningful. That conversion process is where most of the differences in strength and tolerability come from.
The Conversion Chain and Why It Matters
Your skin converts retinoids to the active form in a two-step process. First, retinol is oxidized into retinaldehyde. Then retinaldehyde is oxidized into retinoic acid. The first step is reversible, meaning the skin can push it backward if it has too much retinaldehyde. The second step is irreversible: once retinoic acid is made, it stays as retinoic acid until it is broken down.
This matters practically because each step acts as a bottleneck. When you apply retinol to the skin, your cells only convert a fraction of it into retinoic acid at any given time, which is why retinol is gentler but also less potent than prescription tretinoin. In a skin-model study measuring this conversion, retinol and retinaldehyde both produced roughly similar amounts of retinoic acid in artificial skin after two hours, while retinyl palmitate (a form commonly found in drugstore moisturizers) produced no detectable retinoic acid at all. That finding undercuts the marketing of many products listing retinyl palmitate as their star retinoid ingredient.
Generations of Prescription Retinoids
Topical retinoids have been prescribed for over fifty years, and the molecules available today span four generations. First-generation retinoids include tretinoin, the original and still the most widely prescribed. Chemical modifications over the decades produced a second generation (etretinate and acitretin, used mainly for psoriasis rather than acne), a third generation including adapalene and tazarotene, and most recently a fourth generation represented by trifarotene. Each generation was designed to be more selective in which receptors it targets, which generally means better tolerability or more specific effects.
Adapalene deserves special mention because it crossed from prescription-only to over-the-counter status in many countries. It is more stable in light than tretinoin and tends to cause less irritation, which made it a practical candidate for non-prescription use. Tazarotene, on the other hand, is among the most potent topical retinoids and remains prescription-only. Trifarotene is the newest, designed to target a specific receptor subtype found throughout the trunk and not just the face, making it useful for body acne.
Irritation and What Drives It
The most common complaint about topical retinoids is the initial irritation: redness, peeling, dryness, and sometimes a stinging or burning sensation. This reaction is so predictable it has its own name in dermatology, often called the “retinization” period. It usually peaks in the first two to four weeks and then fades as the skin adjusts.
The irritation is not an allergic reaction. It is an inflammatory response driven by specific signaling molecules. Research on how retinol triggers this irritation found that two proteins in particular, MCP-1 and IL-8, are the main mediators. These are chemical signals that recruit immune cells and cause local inflammation. When retinol or retinoic acid is applied, skin cells ramp up production of both. A separate study using a porcine skin model confirmed that retinoic acid drives basal cell proliferation (thickening the living layers of skin) while simultaneously thinning the outermost protective barrier, increasing water loss through the skin. That combination of a thinner barrier and active inflammation is what makes freshly retinized skin feel raw and sensitive.
One factor that may predict how badly you react: your skin’s baseline microbiome. A multi-omics study found that people who were intolerant to retinol had higher baseline levels of Cutibacterium acnes on their skin before treatment even started, suggesting that the pre-existing microbial landscape plays a role in sensitivity. This is early research, but it hints at why two people using the same product can have wildly different experiences.
How Retinoids Affect the Skin Microbiome
Beyond the connection to irritation tolerance, retinoids appear to reshape the skin’s microbial community in measurable ways. A randomized study comparing a vitamin A acid formulation to benzoyl peroxide in mild acne patients found that both significantly reduced bacterial diversity within the first month. The shifts in community composition were distinct, though: the retinoid and benzoyl peroxide groups showed decreased Cutibacterium and increased Staphylococcus relative abundance, while a different comparator treatment pushed the balance the other way. These microbial shifts may contribute to why some treatments work better for certain people, and they add a layer of complexity that dermatologists are only beginning to account for.
Why Nighttime Application Is Standard Advice
You have probably heard that retinoids should be applied at night. This is not just a suggestion for convenience. The molecule itself, particularly tretinoin, breaks down rapidly when exposed to light. In one study, a conventional tretinoin gel lost more than 83 percent of its active ingredient within two hours of fluorescent light exposure. Even under conditions that simulate a day of indoor lighting rather than direct sunlight, the degradation was severe. Separate research found that a tretinoin lotion degraded to about 20 percent of its starting concentration in just 30 minutes of light exposure, and that the most damaging wavelength was 420 nanometers, which falls in the visible blue-light range rather than the ultraviolet range many people assume is the problem.
Newer formulations have partially addressed this. A micronized tretinoin gel showed only about 11 percent degradation after eight hours of fluorescent light, compared to the 86 percent degradation seen with a conventional gel of a different concentration. Encapsulating tretinoin in liposomes has also shown promise, with one study finding roughly 60 percent of the drug still intact after prolonged light exposure, compared to just 8 percent in a simple solution. These advances matter for real-world use because even nighttime application means the product sits on your skin through to morning, when light exposure begins.
The Moisturizer Sandwich and Application Order
A popular strategy for managing retinoid irritation is the “sandwich” technique: applying moisturizer before and after the retinoid to buffer it against the skin. Research presented at a dermatology conference tested whether this actually undermines the retinoid’s effectiveness. The findings were nuanced. Applying moisturizer either before or after the retinoid (an “open sandwich”) did not significantly reduce the retinoid’s bioactivity compared to using the retinoid alone. But sandwiching the retinoid between two layers of moisturizer (the “full sandwich”) cut its bioactivity by roughly three-fold, likely because the double barrier diluted the product and limited how much penetrated into the skin.
For people in the early weeks of retinoid use, this suggests a practical compromise: applying moisturizer first, then the retinoid on top, preserves most of the product’s effectiveness while providing a buffer. The full sandwich approach is less ideal if your goal is maximum potency, though it may still make sense for someone whose skin is so reactive that they would otherwise stop using the product entirely.
Anti-Aging Effects and Collagen
The anti-aging reputation of retinoids rests on their ability to do two things: stimulate new collagen production and slow the breakdown of existing collagen. The enzymes that chew up collagen in aging and sun-damaged skin are called matrix metalloproteinases, or MMPs. Research on retinoic acid in skin tissue found that it reduced the active forms of two key MMPs, MMP-1 and MMP-9, while simultaneously boosting markers of new collagen and other structural components. In other words, retinoids both slow demolition and speed up construction.
These effects are not limited to cosmetic improvement. The same study demonstrated this capacity in diabetic skin, which is prone to accelerated breakdown of its structural matrix. The implication is that retinoids may help restore structural integrity in skin compromised by disease, not just normal aging.
Long-Term Use
One of the strongest arguments for topical retinoids is the long-term safety and efficacy data. A four-year histological study, the longest of its kind at the time, tracked the skin of patients using tretinoin for photodamage. Over that period, the treated skin showed decreased abnormal elastin accumulation, reduced inflammation around blood vessels, and increased hydrating substances in the outer skin layer. Crucially, there were no harmful effects on the skin’s keratinocytes or melanocytes, the two cell types you would worry about in a treatment that alters cell growth and turnover.
Separate long-term clinical data confirmed that improvements in fine lines, roughness, and discoloration were maintained after twelve months of daily tretinoin use, and that these gains faded gradually if the product was stopped. For people who wanted to maintain results without daily application, using tretinoin just one to three times per week was enough to preserve the visible benefits.
Retinoids and Acne Scarring
Beyond treating active acne, topical retinoids appear to help with the scars left behind. Their effects on keratinization, inflammation, fibroblast activity, and collagen remodeling make them relevant to scar treatment, not just prevention. A review of the available evidence concluded that topical retinoids can improve the appearance of atrophic (depressed) acne scars, slow the progression of scarring during active breakouts, and support the skin’s remodeling process over time. This makes them a reasonable first-line option for mild to moderate scarring, though deeper or more severe scars typically require procedural interventions like lasers or microneedling.
Pregnancy and Reproductive Safety
Oral isotretinoin, the systemic retinoid used for severe acne, is a well-established cause of birth defects. Because topical retinoids belong to the same chemical family, they carry precautionary warnings for use during pregnancy, even though the evidence that they cause harm when applied to the skin is thin. Topical formulations deliver very small amounts of active ingredient into the bloodstream. A review of systemic exposure from topical acne drugs noted that, used appropriately, these products deliver at most minuscule amounts into circulation. Birth defects occurred in two patients using tretinoin and one using adapalene, but in none of these cases was a causal link established.
A large Nordic cohort study framed the issue directly: topical retinoids are commonly used for mild to moderate acne and should be avoided during pregnancy as a precaution, given the known danger of systemic isotretinoin, despite limited safety data on topical use specifically. The practical takeaway is that while the risk from topical application appears very low, the consequences of even a small risk during pregnancy are serious enough that most clinicians recommend stopping use before and during pregnancy. Adapalene and tretinoin are the most commonly discussed in this context.
Bakuchiol as a Plant-Based Comparison
Bakuchiol, a compound derived from the seeds of the Psoralea corylifolia plant, has gained popularity as a “natural retinol alternative.” A randomized, double-blind trial directly compared topical bakuchiol and retinol for facial photoaging over twelve weeks. Both significantly decreased wrinkle surface area and hyperpigmentation, with no statistical difference between the two. The retinol group, however, reported more scaling and stinging. A separate laboratory study added more detail: bakuchiol showed antioxidant activity that retinol lacked, and it significantly promoted skin regeneration in a wound model, while retinol did not.
These are encouraging findings, but they come with caveats. The comparison was with retinol, not with prescription-strength tretinoin. Bakuchiol and retinol are in a similar potency tier, and both are gentler than the prescription forms. Whether bakuchiol can match adapalene or tazarotene for acne or match tretinoin for deep photoaging remains untested. For someone who cannot tolerate retinol or who prefers to avoid retinoids during pregnancy, bakuchiol is a reasonable option. It is not, however, a substitute for prescription retinoids in clinical treatment plans.
New Formulation Strategies
Much of the current research on topical retinoids focuses not on new molecules but on better ways to deliver the existing ones. The major challenges have always been the same: retinoids break down in light, they irritate the skin, and they do not always penetrate evenly. Recent approaches include encapsulating retinoids in nano lipid-based carriers, combining them with antioxidants and soothing agents to offset irritation, and using metal chelators to improve chemical stability. These formulation strategies aim to get more of the active ingredient into the skin in a controlled way while reducing the harshness that causes so many people to abandon treatment in the first few weeks.
Social Media Misinformation
The explosion of skincare content on social media has made retinol one of the most discussed ingredients online, but the quality of that information is poor. A cross-sectional study analyzed the top 150 retinol-related videos across TikTok, Facebook, and Instagram and scored them using DISCERN, a validated tool for evaluating the quality of consumer health information. The mean score across all platforms was 2.13 out of 5, which falls in the “poor” category. No video on any platform included a disclaimer cautioning younger audiences or advising them to consult a physician. This is a real concern given that adolescents, who are heavily represented on these platforms, can develop irritant dermatitis and photosensitivity reactions from unsupervised retinol use.
Common misconceptions circulating online include the ideas that all retinoids are interchangeable, that more product means faster results, that retinoids thin the skin permanently (they actually thicken the living layers while thinning the dead outer layer), and that retinol and tretinoin are the same thing at different price points. The gap between what social media promotes and what the evidence supports is wide enough that dermatologists have started publishing formal analyses of the problem.
Who Should and Should Not Use Them
Topical retinoids are appropriate for most adults dealing with acne, early signs of photoaging, uneven pigmentation, or rough skin texture. They are not appropriate for people who are pregnant or planning to become pregnant, and caution is warranted during breastfeeding and in early childhood due to a lack of relevant studies. People with eczema, rosacea, or severely compromised skin barriers may find that even gentle retinol formulations are too irritating to tolerate, at least without careful dermatologist-guided introduction.
For anyone starting out, the standard advice holds: begin with a low concentration, apply at night, use sunscreen during the day, and give your skin at least six to eight weeks before judging whether the product is working. The irritation in those early weeks is not a sign of damage. It is the predictable inflammatory response that settles as your skin adapts. If it does not settle, a lower concentration, less frequent application, or a switch to a gentler derivative like adapalene or retinaldehyde is the usual next step.